Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TTLL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DEFB108B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPEG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATMIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPNE8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RC3H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCP11L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAN1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on